These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 12271837)
1. Atridox to be used in study to investigate link between heart disease and chronic periodontitis. Dent Today; 2002 Sep; 21(9):32. PubMed ID: 12271837 [No Abstract] [Full Text] [Related]
2. The A-X of Atridox. Sinclair G Ann R Australas Coll Dent Surg; 2000 Oct; 15():157-8. PubMed ID: 11709928 [No Abstract] [Full Text] [Related]
3. A future for periodontal therapy. Gottehrer NR; Martin JL Dent Today; 2010 Feb; 29(2):154, 156-7. PubMed ID: 20196349 [No Abstract] [Full Text] [Related]
7. Assessment of salivary levels of the chosen exoglycosidases in patients with aggressive periodontitis after treatment with doxycycline. Pietruska M; Bernaczyk A; Knaś M; Pietruski J; Zwierz K Adv Med Sci; 2006; 51 Suppl 1():158-61. PubMed ID: 17458082 [TBL] [Abstract][Full Text] [Related]
8. Local delivery of antimicrobials: a new era in the treatment of adult periodontitis. Killoy WJ Compend Contin Educ Dent; 1999; 20(4 Suppl):13-8; quiz 34-5. PubMed ID: 11908359 [TBL] [Abstract][Full Text] [Related]
9. Treatment of severe peri-implant bone loss using autogenous bone and a bioabsorbable polymer that delivered doxycycline (Atridox). Büchter A; Kleinheinz J; Meyer U; Joos U Br J Oral Maxillofac Surg; 2004 Oct; 42(5):454-6. PubMed ID: 15336774 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic agent to slow or arrest periodontitis. J Am Dent Assoc; 2001 Nov; 132(11):1588-9. PubMed ID: 11811137 [No Abstract] [Full Text] [Related]
11. An orally administered drug for treatment of periodontal disease. Caton JG Pract Periodontics Aesthet Dent; 1997 May; 9(4):465-6. PubMed ID: 9550073 [No Abstract] [Full Text] [Related]
12. Effects on the clinical indices and gingival crevicular fluid enzyme activities of the cyclical regimen of low-dose doxycycline therapy for adult periodontitis. Alptekin NO; Kurtoglu F; Serpek B; Duran I; Gözlü M J Int Acad Periodontol; 2000 Jan; 2(1):3-8. PubMed ID: 12666979 [TBL] [Abstract][Full Text] [Related]
13. Clinical applications for host modulatory therapy. Ryan ME Compend Contin Educ Dent; 2002 Nov; 23(11A):1071-6, 1079-80, 1082. PubMed ID: 12789987 [TBL] [Abstract][Full Text] [Related]
14. Using host response modifiers in the treatment of periodontal disease. Novak MJ; Donley TG Pract Proced Aesthet Dent; 2002; 14(9):suppl 3-10; quiz 11. PubMed ID: 12685424 [TBL] [Abstract][Full Text] [Related]
15. The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Górska R; Nedzi-Góra M Arch Immunol Ther Exp (Warsz); 2006; 54(6):419-26. PubMed ID: 17122880 [TBL] [Abstract][Full Text] [Related]
16. Using host response modifiers in the treatment of periodontal disease. "The clinicians' view". [Interview]. Chichetti S; Bader H; Smith S; Barnett N; Barecki R; Testa D; Giannini J; Bass D; Vines I; DiSalvo P Pract Proced Aesthet Dent; 2002; 14(9):suppl 12-5. PubMed ID: 12685429 [TBL] [Abstract][Full Text] [Related]
17. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. Haffajee AD; Torresyap G; Socransky SS J Clin Periodontol; 2007 Mar; 34(3):243-53. PubMed ID: 17309596 [TBL] [Abstract][Full Text] [Related]
18. Local delivery of antimicrobial drugs in the treatment of chronic adult periodontitis. Pappalardo S; Baglio OA; Cappello C; Guarrera S; De Benedittis M; Petruzzi M; Grassi RF Minerva Stomatol; 2006; 55(11-12):655-61. PubMed ID: 17211371 [TBL] [Abstract][Full Text] [Related]
19. Low-dose doxycycline (Oracea) for rosacea. Med Lett Drugs Ther; 2007 Jan; 49(1252):5-6. PubMed ID: 17220813 [No Abstract] [Full Text] [Related]